Filing Details
- Accession Number:
- 0001562180-19-005422
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-08 17:28:54
- Reporting Period:
- 2019-11-06
- Accepted Time:
- 2019-11-08 17:28:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434418 | Constellation Pharmaceuticals Inc | CNST | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1616230 | Adrian Senderowicz | C/O Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200 Cambridge MA 02142 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-06 | 27,232 | $5.51 | 43,116 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-06 | 5,431 | $20.01 | 37,685 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 5,451 | $25.18 | 32,234 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 10,899 | $30.14 | 21,335 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-06 | 5,451 | $35.11 | 15,884 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-11-06 | 27,232 | $0.00 | 27,232 | $5.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 109,020 | 2027-07-10 | No | 4 | M | Direct |
Footnotes
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $20.00 to $20.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $25.00 to $25.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $30.00 to $30.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $35.00 to $35.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on July 11, 2017, and has vested as to 25% of the shares underlying the option as of July 10, 2018 with the remainder vesting quarterly through July 10, 2021.
Billionaire Hedge Funds
